Publications by authors named "Walter Urba"

Claim this Profile
W
Widespread Adoption of Precision Anticancer Therapies After Implementation of Pathologist-Directed Comprehensive Genomic Profiling Across a Large US Health System.
Alexa K Dowdell, Ryan C Meng, Ann Vita, Bela Bapat, Douglas Hanes, Walter J Urba

JCO Oncol Pract· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Timothy L Cannon, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Vi K Chiu, Walter J Urba

J Clin Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Funda Meric-Bernstam, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Rodolfo Gutierrez, Walter J Urba

JCO Precis Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer's Dark Matter: Lighting the Abyss Unveils Universe of New Therapies.
Bernard A Fox, Walter J Urba, Shawn M Jensen, David B Page, Brendan D Curti

Clin Cancer Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer.
David B Page, Joanna Pucilowska, Brie Chun, Isaac Kim, Katherine Sanchez, Walter J Urba

NPJ Breast Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced -Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.
Michael B Atkins, Sandra J Lee, Bartosz Chmielowski, Ahmad A Tarhini, Gary I Cohen, Walter J Urba

J Clin Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Random Forest Genomic Classifier for Tumor Agnostic Prediction of Response to Anti-PD1 Immunotherapy.
Emma Bigelow, Suchi Saria, Brian Piening, Brendan Curti, Alexa Dowdell, Walter Urba

Cancer Inform· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial.
Tomoko Yamazaki, Andrew J Gunderson, Miranda Gilchrist, Mark Whiteford, Maria X Kiely, Walter J Urba

Lancet Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer. Reply.
Eric Tran, Walter J Urba, Rom Leidner

N Engl J Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer.
Rom Leidner, Nelson Sanjuan Silva, Huayu Huang, David Sprott, Chunhong Zheng, Walter J Urba

N Engl J Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer.
Brie Chun, Joanna Pucilowska, ShuChing Chang, Isaac Kim, Benjamin Nikitin, Walter J Urba

J Immunother Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab.
Yoshinobu Koguchi, Noriko Iwamoto, Takashi Shimada, Shu-Ching Chang, John Cha, Walter J Urba

J Immunother Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Antibodies Detected in Mother's Milk Post-Vaccination.
Jill K Baird, Shawn M Jensen, Walter J Urba, Bernard A Fox, Jason R Baird

J Hum Lact· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma.
Rom Leidner, Marka Crittenden, Kristina Young, Hong Xiao, Yaping Wu, Walter J Urba

J Immunother Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells.
Rebekka Duhen, Carmen Ballesteros-Merino, Alexandra K Frye, Eric Tran, Venkatesh Rajamanickam, Walter J Urba

Nat Commun· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma.
Catherine S Grasso, Jennifer Tsoi, Mykola Onyshchenko, Gabriel Abril-Rodriguez, Petra Ross-Macdonald, Walter J Urba

Cancer Cell· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
Jason D Goldman, George Diaz, Walter J Urba

Int J Antimicrob Agents· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer.
Katherine Sanchez, Isaac Kim, Brie Chun, Joanna Pucilowska, William L Redmond, Walter J Urba

Breast Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma.
Catherine S Grasso, Jennifer Tsoi, Mykola Onyshchenko, Gabriel Abril-Rodriguez, Petra Ross-Macdonald, Walter J Urba

Cancer Cell· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma.
John Timmerman, Charles Herbaux, Vincent Ribrag, Andrew D Zelenetz, Roch Houot, Walter Urba

Am J Hematol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response.
Fernanda I Arnaldez, Steven J O'Day, Charles G Drake, Bernard A Fox, Bingqing Fu, Walter J Urba

J Immunother Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma.
Brendan Curti, Marka Crittenden, Steven K Seung, Christopher B Fountain, Roxanne Payne, Walter J Urba

J Immunother Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase Ib Study of Preoperative, Locoregional IRX-2 Cytokine Immunotherapy to Prime Immune Responses in Patients with Early-Stage Breast Cancer.
David B Page, Joanna Pucilowska, Katherine G Sanchez, Valerie K Conrad, Alison K Conlin, Walter J Urba

Clin Cancer Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.
Paolo Antonio Ascierto, Bernard A Fox, Walter J Urba, Ana Carrizosa Anderson, Michael B Atkins

J Immunother Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distance.
Marcus A Couey, R Bryan Bell, Ashish A Patel, Meghan C Romba, Marka R Crittenden, Walter J Urba

J Immunother Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis